EMCDDA Home
  • EN
Search

Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2010 or most recent year available

Part (iv) New hallucinogen outpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium121000000303
Bulgaria00000000000
Czech Republic10000000112
Denmark00300000303
Germany41230000019625
Estonia2:::::::::::
Ireland10100000202
Greece01100000202
Spain3417721000311445
France71521201129433
Italy402000000020424
Cyprus00000000000
Latvia511000000224
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary11100000303
Malta6:::::::::::
Netherlands72372711472292144236
Austria02000000202
Poland801000000101
Portugal902100000303
Romania13100000505
Slovenia00000000000
Slovakia00000000000
Finland00000000000
Sweden01010000202
Uk1021456122742024346289
Croatia:::::::::::
Turkey:::::::::::
Norway:::::::::::
Total2625910837141153463221684
 

Notes:

: Indicates no data are available

(1) In Belgium if the exact primary drug is not known, the generic category is recorded. In 2010 there were198 Opiates, 7 Cocaine, 7 Stimulants, 2 Hypnotics and Sedatives and 1 Hallucinogens clients with the primary exact drug unknown. Of which 24 and 5 were new clients for respectively Opiates and Stimulants.

(2) Data are from outpatient, inpatient treatment centres and prisons (aggregated data).

(3) Data are from 2009. Data are from Outpatient treatment centres and some treatment units in prison (aggregated data).

(4) In 2010 around 29% of all clients and 30% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(5) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(6) Data refers to outpatient and inpatient treatment centres, low-threshold services and prisons (aggregated data).

(7) Data are from outpatient, inpatient treatment centres and Low-threshold services (aggregated data).

(8) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(9) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(10) Data are from 1st of April 2009 to 31st March 2010.

See also 'tdi-11-p12345678-07-Age at first use distribution summary.xls' 'parti' and 'partii', and 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2011 REITOX National Reports - Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 09 July 2012